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The global burden of cancer is escalating as a result of dramatic increases in the use of tobacco in the developing world. The use of
tobaccoislinkedtothedevelopmentofabroadvarietyofcancers,mainlylungcancer,thesinglemostcommoncancerintheworld.
Tobacco smoking-attributable deaths extends beyond cancer and include stroke, heart attack and COPD. Widening disparities
in cancer-related mortality have shifted towards a more dramatic burden in the developing world. Appropriate interventions
must be implemented to reduce tobacco use and prevent global mortality that has escalated to epidemic levels. Tobacco control
policies, including public health advertisement campaigns, warning labels, adoption of smoke-free laws, comprehensive bans and
taxpoliciesarehighlyeﬀectivemeasurestocontroltobaccouse.Cliniciansandacademicinstitutionshavetobeactivelycommitted
to support tobacco control initiatives. The reduction in cancer related morbidity and mortality should be viewed as a global crisis
and deﬁnitive results will depend on a multilevel eﬀort to eﬀectively reduce the burden of cancer, particularly in underprivileged
regions of the world.
1.Introduction
The global burden of cancer is escalating, largely due to dra-
maticincreasesintheuseoftobaccoinlessdevelopednations
[1]. Indeed, overall cancer rates appear to be increasing in
developingcountries,evenwhiletheyremaingenerallystable
or show small decreases in many industrialized countries
[2, 3]. Thus, global changes in tobacco use may eventually
produce large disparities in cancer-related mortality rates
between the developed and less developed countries of the
world [4].
The purpose of this paper is to highlight the trend
towards increased tobacco use and the increasing cancer
burden in developing countries and suggest steps that might
be taken to reverse this alarming trend.
Tobacco was widely used by the Mayans and other Native
Americans well before Christopher Columbus introduced it
to Europe in 1492. Within 150 years after its introduction
to Europe, tobacco use was common throughout the world.
Over the centuries, the methods of tobacco usage have
changed considerably. In the 18th century, snuﬀ held sway;
the19thcenturywastheageofthecigar;the20thcenturysaw
the rise of the manufactured cigarette and with it a greatly
increased number of smokers [5]. Although the worldwide
use of tobacco has steadily increased since the 16th century,
early public statements showed its disapproval as stated by
James I of England in his Counterblaste to Tobacco in 1604:
“Smoking is a custom loathsome to the eye, hateful to the
nose,harmfultothebrain,dangeroustothelungs,andinthe
black, stinking fume thereof nearest resembling the horrible
Stygian smoke of the pit that is bottomless.” Thus, even
thoughitshealthriskshavebeenacknowledgedforcenturies,
tobacco use throughout the world continues to increase.
Most people who use tobacco regularly do so because of
their addiction to nicotine, a major component of cigarettes.
Although the majority of users express a desire to reduce
their use or stop entirely, overcoming the addiction is
diﬃcultandmayrequirebothpharmacologicandbehavioral
treatments. Recent research has clariﬁed the addictive nature
of nicotine, and it appears to be similar to that of the opiates,
cocaine, or other illicit drugs [6, 7].
Environmental factors likely also contribute to the
increased use of cigarettes. For many, the behavior of
smoking is not simply a matter of addiction, nor one of poor
self-image, but also occasionally to underlying mental illness
[8].2 Journal of Oncology
2.Tobacco-Associated Cancers
The association between tobacco and lung cancer was
initially demonstrated by Doll and Hill in the 1950s in
the UK [9]. Since then, additional case-control studies [10]
and prospective cohort studies [11]h a v ea l la ﬃrmed the
association between tobacco and the development of lung
cancer. Indeed, lung cancer was rare in the early decades of
the 20th century, but with the increase in smoking tobacco,
it has become an alarming epidemic.
The tobacco hazard, although clearly linked to the
development of lung cancer, also causes an increased risk
of several other cancers, notably oral, larynx, pharynx,
esophagus, stomach, liver, pancreas, kidney, bladder, uterine
cervix cancers, and myeloid leukemia [12].
There is a clear dose-response relationship between
cancer risk and tobacco use. A lifetime smoker has a risk
20–30 times greater than of a nonsmoker [13]. More than
4,000 chemicals have been identiﬁed in tobacco smoke,
and some 60 are known or suspected carcinogens [14].
Each cigarette brings approximately 10mg of soot, tar, ash,
phenols, benzpyrene, hydrogen cyanide, formaldehyde, and
radioactive polonium 210 into the lungs of the smokers [5].
3. The Global Problem
Worldwide, cancer is responsible for 1 out of every 8
deaths (more than HIV/AIDS, tuberculosis and malaria
combined [15]), and tobacco use is responsible for one-third
of all cancer-related deaths [16]. The International Agency
for Research on Cancer (IARC) estimates that there were
approximately 12.7 million new cases of cancer diagnosed in
theworldin2008,and7.6milliondeathsattributedtoit[17].
Furthermore, tobacco is responsible for 87% of all
deaths attributable to lung cancer [18], now the single most
common cancer in the world. It is estimated that by 2030
lung cancer will be the sixth most common cause of death in
the world, compared with its current ranking of ninth [19].
Tobacco smoking-attributable illness extends beyond
cancer and includes stroke, heart attack, and COPD. Indeed,
total tobacco-attributable deaths are projected to rise from
5.4 million in 2005 to 6.4 million in 2015 and to 8.3 million
in 2030 [19], with an estimated 600,000 deaths attributable
to second-hand smoke [20]. These projections are based on
models that show a three- to four-decade lag between the
rise in smoking prevalence and the increase in smoking-
attributable mortality that results from it [21].
Yet, if appropriate measures to control tobacco were
implemented, a large proportion of these deaths could be
averted. A number of indirect methods to estimate the
mortality attributable to tobacco use have been developed;
however, limitations related to speciﬁc countries and age
population groups have been noted in the literature [22–25].
Unless there is widespread cessation of smoking, approxi-
mately450milliondeathswilloccurasaresultofsmokingby
2050, and most of these will occur in current smokers [26].
For instance, the global burden of lung cancer has shifted
signiﬁcantly from approximately 31% of cases occurring
in developing countries, to now up to 55% occurring in
these countries [27]. This makes the widening disparities in
cancer-related mortality between developed and developing
countries even more tragic. Indeed, the World Health Orga-
nization (WHO) estimates that 40% of all cancers diagnosed
today could have been prevented, partly by maintaining
healthy diet, promoting physical activity, and preventing
infections that may cause cancer, but largely through tobacco
control [28].
Although the contribution of tobacco use to disease and
death is well known, less attention has been given to the
ways in which tobacco increases poverty and broadens social
inequalities[29].Forexample,inVietnam,theamountspent
on cigarettes ($US 416.7 million) is enough to feed 10.6–
11.9 million people per year [30]. Furthermore, it has been
reported that in China, poor individuals may spend up to
60% of their income on cigarettes, taking away money from
food and children education [31]. Serious environmental
problems are also associated with tobacco production, which
requires the greater use of fertilizers and pesticides and
massive deforestation for curing tobacco leaves. One tree is
wasted for every three hundred cigarettes produced, and it is
estimated that land used for tobacco cultivation worldwide
could potentially be used to feed about 10 to 12 million
people [32]. As in other agricultural sectors, child labor is
prevalent in the tobacco farms, particularly in the poorer
areas, where up to 80% of children are missing school and/or
undertaking hazardous tasks due to farm work [33].
Currently, smoking imposes a huge economic burden
in developed countries, responsible for 15% of the total
healthcare costs [34]. Developing countries, with higher
population growth rates, are not prepared to cope with such
increases in their healthcare expenditures.
4. Tobacco Industry
In many industrialized countries, tobacco use appears to be
declining, largely due to the diligent eﬀorts of public health
oﬃcials.Inresponsetothesedeclines,thetobaccoindustryis
now targeting third world markets, not only to expand their
markets, but also as a source of less expensive tobacco.
Thetobaccoindustryincludessomeofthemostpowerful
transnational companies in the world. These companies
sell about six trillion cigarettes each year, which accounts
for the largest share of manufactured tobacco products,
comprising 96% of the total value sales [35]. The industry
is highly concentrated within a handful of ﬁrms. The
global tobacco market, valued at US$ 378 billion, grew
by 4.6% in 2007 and by the year 2012 is expected to
increaseanother23%,reachingUS$464.4billion[36].China
is the biggest tobacco market, based on total cigarettes
consumed. There are some 350 million smokers in China
who consume around 2,200 billion cigarettes a year, or about
41% of the global total. However, the industry in China is
state owned. Outside of China, the four largest publicly-
listed international tobacco companies account for about
46% of the global market. Although the tobacco compa-
nies have experienced declines in proﬁts in industrializedJournal of Oncology 3
countries, their overall proﬁts are increasing, driven by
world population growth, particularly in Asia. The tobacco
companies have reacted to stagnating demand on their
traditional markets in basically three ways: consolidation
(dominating the business by few but very inﬂuential com-
panies), diversiﬁcation (by producing low- and high-quality
cigarettes and geographic diversiﬁcation), and increasing
productivity [37]. Worldwide, even if the prevalence of
tobacco use falls, the absolute number of smokers will
increase due to the huge population of the developing world
[38].
The giant multinational cigarette companies generally
ﬁnd that the political and social climate in the developing
world is conducive to their business [39]. Governments in
these countries use tobacco taxation as a source of much
needed revenue and, therefore, do very little to discourage
tobacco use. Furthermore, people in the developing world
are generally much less knowledgeable about the health risks
associated with cigarettes, and there exist very few anti-
smoking campaigns, with tobacco products often carrying
no health warnings [40]. In Pakistan, for example, health
warnings, even if available, tend to be very vague and poorly
understood [41]. High-tar cigarettes, banned in developed
countries, continue to be sold in the developing world. For
example, nicotine contents for Indonesian kreteks or clove
cigarettes are between 1.7 and 2.5mg per stick compared
with<0.05 and 1.4mg per stick for cigarettes sold in the USA
[42].
Yet, the tobacco companies are continuing their market-
ing eﬀorts in the industrialized countries as well. Although
no other consumer product is more dangerous or kills as
many people as does tobacco, it still remains the most
advertised product in the USA, with estimated advertising
expenditures in the tens of billions of US dollars every year
[35].
Facing global antitobacco forces, the tobacco industry
is already moving beyond what they refer to as “light”
and “mild” cigarettes to a new generation of tobacco prod-
ucts referred to as “potential-reduced exposure products”
(PREPs) [43] .T h e s ep r o d u c t s ,w h i c hh a v eb e e ni nd e v e l o p -
ment for decades, are the next step after ﬁlters and low-
delivery “light” and “mild” cigarettes. The essential idea
behind PREPs is that they will deliver the levels of nicotine
required for a smoker’s addiction with less (but some) of
the toxins associated with smoking [44]. Yet, these products
clearly are associated with alarming health risks, downplayed
by the tobacco industry.
In May, 1999, researchers of the World Bank’s Health,
Nutrition and Population sector published a paper entitled
“Curbing the Epidemic: Governments and the Economics of
Tobacco Control.” This document concluded that tobacco
control is not only good for health, but also good for
the economy. Yet, multinational tobacco companies have
attempted to use their own “economic impact studies” to
convince governments that, contrary to the World Bank’s
conclusion, tobacco use beneﬁts the economy. Thus, the
tobacco industry continues its diligent eﬀorts to undermine
any threat to its proﬁts. There are several investigators
who have argued that the tobacco industry propagates
disinformation, manipulates research, and generates faulty
information concerning the eﬀects of tobacco use and
second-hand smoke [7, 45].
5. The Growing Problem in
the Developing World
Worldwide, cigarette consumption is increasing at a rate of
about 3% annually. In Asia, Southern and Eastern Europe,
and developing countries, tobacco use is increasing at about
8% per year. Yet, in some industrialized countries, smoking
rates are decreasing at about 1% a year, largely due to
the implementation of signiﬁcant anti-tobacco programs.
As with all other epidemics involving a major behavioral
component, the exact timing, duration, and magnitude
of the smoking epidemic will vary signiﬁcantly from one
country to another. In China and many other developing
countries, the rate of tobacco-related deaths is rising rapidly.
Chinaisnowbeginningtofacethedetrimentalconsequences
of tobacco use, as many millions of individuals who began
smoking in adolescence are now aging. Yet, it will be
around 2030 before the epidemic of tobacco-related deaths
peaks in China at the level achieved in the United States
in 1990 [46]. Indeed, lung cancer rates in China have
already been increasing about 4.5% a year. These trends
reﬂect signiﬁcant policy deﬁciencies towards tobacco use in
developing countries.
Most cigarettes are now consumed and produced in
Asia. China alone produces close to 40 percent of world
total, followed by India, Brazil, and USA (Figure 1). Neither
tobacco nor cigarettes are a homogeneous product. Diﬀerent
conditions in the tobacco growing areas, (type of soil,
rainfall, irrigation, and climate) handling and processing,
ultimately will inﬂuence the quality of the leaf and the
smoking product. Most manufacturers use a blend of
diﬀerent tobaccos in their product. However, the tobacco’s
leaf quality and additive contents will aﬀect the particular
taste of a cigarette brand and certainly the price [47].
The increasing incidence of cancer in developing coun-
tries reﬂects a transition in the global burden of disease
away from one previously dominated by infectious diseases.
This shift is also partly due to the ageing of the population
and public health interventions such as vaccinations and the
provision of clean water and sanitation in the developing
world, all of which have served to reduce the burden of
infectious diseases.
Also some of the environmental, social, and structural
changes linked to the transformation of a country from
agrarian to industrial and then to a postindustrial state may
lead to increased longevity in the population. As cancer is
more common in the older age groups, cancer rates are
expected to increase accordingly.
Yet, public health interventions can eﬀectively lower the
cancer rates. Low- and middle-income countries, faced with
the tobacco epidemic, can learn from the tobacco-control
successes in high-income countries by enacting cost-eﬀective
tobacco-control policies. Such policies can eﬀectively reduce
the burden of cancer.4 Journal of Oncology
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Figure 1: World land devoted to growing tobacco. The Tobacco Atlas, third edition. “Reprinted by the permission of the American Cancer
Society, Inc., The Tobacco Atlas, 3rd Edition. American Cancer Society 2009, http://www.cancer.org/.A l lr i g h t sr e s e r v e d . ”
6.GlobalApproaches to anEscalating
Cancer Burden
Many interventions (public health advertising campaigns,
warning labels on tobacco products, etc.) that were devel-
oped in the industrial world to curb tobacco use should be
urgentlyimplementedinthedevelopingworld.Interventions
to reduce tobacco use may not only avert a large burden of
unnecessary deaths, but also save governments huge health
care costs. To prevent death or morbidity from cancer,
interventions should target behaviors or risk factors that are
responsible for tobacco use, and these interventions should
be cost eﬀective [48].
The Disease Control Priorities Project (DCPP), a joint
eﬀort of the Fogarty International Center of the US National
Institutes of Health (NIH), World Health Organization
(WHO), and The World Bank, was launched in 2001. This
projectaimstoassistdecisionmakersindevelopingcountries
ﬁnd aﬀordable, eﬀective interventions to improve the health
and welfare of their populations [49].
The spirit of international cooperation is exempliﬁed
in The Tobacco Control Country Proﬁles database, a data
collection initiative led by the American Cancer Society, the
World Health Organization (WHO), and the Centers for
Disease Control and Prevention. It represents a worldwide
information system to support global tobacco control eﬀorts
[50].
The World Health Organization (WHO) has led interna-
tional strategies to eradicate tobacco use. The WHO Frame-
work Convention on Tobacco Control (FCTC), the ﬁrst
global treaty in response to the tobacco epidemic, adopted in
2003, sets the foundation for price and nonprice population-
based control interventions to reduce both demand for and
supply of tobacco products and provides a comprehensive
direction for tobacco control policy at all levels (Table 1).
As of October 2010, 172 countries have ratiﬁed the treaty,
representing 87.3% of the world’s population. Up to a
21% reduction in smoking prevalence can potentially be
achieved by implementing important interventions, such
as increased taxes on tobacco products, enforcement of
smoke-free workplaces, controls on packaging and labeling
of tobacco products, and a ban on tobacco advertising,
promotion, and sponsorship [51].
The Tobacco Control Program of the WHO was devel-
oped in response to the globalization of tobacco use. It
is based on the principles of the FCTC, provides data-
supported eﬀective measures for tobacco control at all levels,
and launches an annual global report summarizing the
most current status of the application of those strategies. In
2008, WHO introduced a package of principles under the
acronym of MPOWER intended to assist in the country-level
implementation of eﬀective measures to reduce the demand
for tobacco. Table 2 summarizes those key points.
There are dozens of more national and international
nongovernmental organizations which address tobacco con-
trol as part of their activities and numerous additional
partner organizations that promote tobacco control among
their initiatives [35].
Despite signiﬁcant improvements worldwide in cancer
diagnosis and treatment, much still remains to be done
[52]. Cancer is a global challenge. Health-oriented resources
should be allocated to collect accurate cancer data [53]. InJournal of Oncology 5
Table 1: Key policy provisions of the WHO framework convention
on tobacco control [8].
FCTC article
no. Policy
6 Price and tax measures to reduce demand.
8 Protection from exposure to tobacco smoke.
9 Regulation of the contents of tobacco products.
10 Regulation of tobacco product disclosures.
11 Controls on packaging and labeling of tobacco
products.
12 Programs of education, communication, training,
and public awareness.
13 Bans on tobacco advertising, promotion, and
sponsorship.
14 Programs to promote and assist tobacco cessation,
and prevent and treat tobacco dependence
15 Elimination of illicit trade in tobacco products.
16 Measures to prevent the sale and promotion of
tobacco to young people.
17 Provision for support for alternative crops to
tobacco.
20 Provision for an epidemiologic monitoring
system.
22
Cooperation among the parties to promote the
transfer of technical and scientiﬁc expertise on
surveillance and evaluation.
Table 2: World Health Organization MPOWER key points [1].
Monitor tobacco use and prevention policies.
Protect people from tobacco smoke.
Oﬀer help to quit tobacco use.
Warn about the dangers of tobacco.
Enforce bans on tobacco advertising, promotion, and sponsorship.
Raise taxes on tobacco.
developing countries, cancer registries are perceived as a
luxuryandrarelyprovidedsuﬃcientresources.International
scientiﬁc societies have deﬁned standards for cancer data
collection, starting with a hospital-based registry which can
be the ﬁrst step towards the formation of a population-
based cancer registry. The major aim of a cancer registry is
to produce and interpret data to develop country-speciﬁc
research protocols and cancer control plans [54].
In high-income countries, comprehensive bans on all
advertising, promotion, and sponsorship protect people
from industry marketing tactics and decrease tobacco con-
sumption by approximately 7%. It has been suggested that
these preventive measures might be twice as eﬀective in low
and middle-income countries potentially reducing global
cancer mortality rates [55, 56]. The Family Smoking Preven-
tionandTobaccoControlAct,aUnitedStatesfederallawthat
gives the Food and Drug Administration (FDA) the power to
regulate the tobacco industry, was signed into law on June
22, 2009 by President Barack Obama. The Tobacco Control
Act requires that cigarette packages and advertisements have
larger and more visible graphic health warnings (including
nine new textual warning statements and color graphics
depicting the negative health consequences of smoking) and
a prohibition on the manufacture of products that use the
terms “light,” “low,” “mild”, and similar descriptors [57].
Tax policies that raise the price of tobacco products are
the single most eﬀective approach for reducing demand,
since consumption is highly inﬂuenced by the extent to
which smokers can aﬀord to purchase cigarettes [58]. Price
increases are especially eﬀective against the initiation of
smoking in youth and motivating addicted smokers to
quit [59]. A 10% price increase may cause a 4% drop in
tobacco consumption in high-income countries and an 8%
drop in low- and middle-income countries, in addition to
increasing tobacco tax revenue [60]. Additional price cap
regulations (wherein a cap is placed on the pretax cigarette
manufacturers’ price) limits excess proﬁts for the tobacco
industry and increases government revenue [61].
The magnitude of the price increase is one of the
most important predictors of an intention to quit/smoke
compared with the average cigarette price. However, the
availability of alternative (cheaper) cigarette sources may
reduce but would not eliminate the impact of higher
prices/taxes on the expected intention to stop smoking [62].
Illegally sold cigarettes evade taxes, and indeed, smugglers
put cheap cigarettes into the hands of those most vulnerable,
the developing countries, where those activities have been
rising exponentially. Tobacco has now become the world’s
most widely smuggled legal substance. The World Health
Organization estimates that as many as 25% of all cigarettes
sold in the world are smuggled. For the international gangs
that organize the traﬃc, it is even more proﬁtable than drug
smuggling [63].
Cessation programs have been shown to provide beneﬁts
to certain populations [64]. Cessation programs have a role
at all levels of the health workforce, including primary care,
health specialists, and smoking cessation specialists.
Adoption of smoke-free laws, included in the article
8 guidelines of the FCTC, has been shown to reduce
hospital admission for heart attacks and results in an overall
decrease in acute coronary events [65]. Multiple successful
examples of countries and cities around the world that have
implemented smoke-free laws support the fact that with
adequate planning and resources, tobacco-free enforcement
protect health and proﬁts the economy [66]. Latin America
r e m a i n sa tt h ef o r e f r o n to fg l o b a lp r o g r e s sw i t hC o l o m b i a ,
Guatemala, Paraguay, Peru, and Honduras recently added
to that growing list [67]. The European Union is proposing
a full-scale ban on branded cigarettes, forcing tobacco
companies across the continent to sell their products in
generic, plain packaging. Worldwide, 25 countries already
switched from text to graphic health warnings [68].
Internationalorganizationsandgovernmentshavefound
certain constraints and barriers to succeed in the war
against tobacco: lack of adequate technical and ﬁnancial
resources and capacities for tobacco control; weakness or
lack of eﬀective national legislation on tobacco control; lack
of public and media awareness of the harmful eﬀects of
tobacco use; tactics of the tobacco industry in hindering6 Journal of Oncology
eﬀective implementation of already adopted legislation or
interference in the development of such legislation; lack of
or insuﬃcient political will or intersectoral cooperation in
tobacco control [69].
Tobacco control policies implemented in high-income
countries may not necessarily have a similar eﬀect in low-
and middle-income countries, and public health oﬃcials
should consider this possibility when planning appropriate
interventions [70]. In summary, the deﬁnitive results in
public health improvement will depend on how aggressive
a particular government is on implementing the elements of
the WHO’s FCTC.
7. ClinicianandAcademic
Institution-BasedInitiatives
Many of the cancers that pose the greatest threat to
developing countries are directly linked to tobacco use. In
developed countries, most patients have access to a full
range of healthcare resources, including smoking cessation
programs, but this is not the case in the developing world.
In the developing world, primary care physicians and health
workers will need to be more involved in cancer control
through health promotion programs that emphasize the
hazards of tobacco use and prioritize tobacco cessation.
Moreover, many low- and middle-income countries will
likely see greater increases in quality-adjusted life years
(QALYs) through implementation of smoking cessation
interventions, tax policies, bans of promotion and adver-
tisement, and adoption of smoke-free laws, mainly because
tobacco-related cancers are preventable, and specialty cancer
care is often limited in these countries [15].
The role of the health professionals is critical in tobacco
control. At the local level, brief clinical interventions should
be implemented based on patient’s willingness to quit.
Strategies should be implemented to advise patients to quit,
to reinforce their decision to quit, and identify those who
are at risk for relapse to smoking, providing such individuals
with counseling, pharmacotherapy, or both [71].
Unfortunately, in many countries, the prevalence of
health professional smokers is similar to that of the general
population.Tosetanexample,healthprofessionalsshouldbe
urged to stop smoking [72]. Thus, the eradication of tobacco
should become a priority for not only governments, but also
medical schools and physicians.
Multiple studies have shown that there are diﬀerences
in patient approach, assistance [73], and educational role
betweensmokingversusnonsmokingphysicians[74].Smok-
ing physicians beneﬁt from practical assistance in quitting
themselves and providing support to their patients [75]. In
2008, the U.S. Department of Health and Human Services
launched a Clinical Practice Guideline, which summarizes
the most updated recommendations in clinical treatments
for tobacco dependence based on systematic review of
evidence-based research that should be implemented by
every physician [64]. Along the eﬀective strategies available,
clinicians also must be committed to follow a code of
professional ethics regarding tobacco. Those should include
(1) physicians not smoking,
(2) make tobacco cessation assistance a routine part of
oncology care,
(3) establish all medical facilities to be 100% smoke-free,
(4) teaching physicians should lead their students to
never become smokers and train them in the prin-
ciples of smoking cessation,
(5) reject any involvement of the tobacco industry in
ﬁnancing research, training programs, or treatment
services for patients,
Several international societies have trained medical and
surgical oncologists as part of their eﬀort to address the bur-
den of cancer in developing countries. Available educational
resources for clinicians in developing countries include the
EuropeanSchoolofOncology(ESO),theInternationalCam-
paign for the Establishment and Development of Oncology
Centres (ICEDOC), the Global Core Curriculum in Clinical
Oncology developed by the European Society for Medical
Oncology (ESMO), and the American Society for Clinical
Oncology (ASCO), among several others [76, 77].
Unfortunately, some academic institutions have received
funds from the tobacco industry to support biomedical
research. Universities and researchers must understand the
motivationunderlyingsuchoﬀersofsupport.Bylegitimizing
the tobacco industry, universities risk their integrity, values,
and public trust [78]. Academic institutions should therefore
reject oﬀers of funding from the tobacco industry.
8. Conclusion
The reduction of cancer-related morbidity and mortality
in developing countries should now become an urgent
global priority. Developing countries already have enormous
limitations in resources and are unable to cope with an
escalating cancer burden. Additionally, an escalating cancer
burden in developing countries is not in the best interests of
the developed world and should be viewed as a global crisis.
Urgent eﬀorts are now needed to curb the widespread use of
tobacco and thereby eﬀectively reduce the burden of cancer,
particularly in underprivileged regions of the world.
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